The insider buying cluster, particularly the $5.0M purchase by a director with deep industrial expertise, signals confidence in GEHC's long-term value despite near-term headwinds. Monitor for additional insider purchases in the next 30 days and any pre-announcements or guidance updates that could validate this vote of confidence. The stock's reaction to the earnings miss may be overdone if insiders are correct.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · May 1 $60.96entry
- T+1 · 7mo ago −0.05%α +0.32% · $60.93
- T+5 · 6mo ago +4.00%α +1.64% · $63.40
- T+20 · 6mo ago +2.72%α −2.54% · $62.62
- T+60 · 4mo ago +17.88%α +16.39% · $71.86
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
GE HealthCare insiders, including director H. Lawrence Culp Jr. ($5.0M), CEO Peter Arduini ($250K), and CFO James Saccaro ($201K), collectively purchased $5.62M in open-market shares over the past week. This cluster follows the company's Q1 2026 earnings miss and lowered full-year guidance, suggesting insiders view the post-earnings dip as an attractive entry point. The buying is material at ~0.02% of market cap and is amplified by the proximity to the earnings release.
Key Financial Metrics
Key Facts
- Total insider purchases of $5.62M over 7 days, led by director H. Lawrence Culp Jr. ($5.0M at $61.88)
- CEO Peter Arduini bought $250K, CFO James Saccaro bought $201K, GC Frank Jimenez bought $106K
- Director William Stromberg bought $62K and also received a non-cash grant of 3,586 shares
- Cluster follows Q1 2026 earnings miss (Adjusted EPS $0.99 vs $1.07 consensus) and lowered FY2026 guidance
- Buying represents ~0.02% of GEHC's $28.9B market cap, modest but notable given C-suite participation
Financial Impact
Total insider purchases of $5.62M, representing ~0.02% of market cap
Risk Factors
- Insider buying does not guarantee near-term stock performance; guidance was lowered for FY2026
- Macro headwinds (memory chip inflation, oil, freight costs) and PDx supplier issue remain unresolved
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-GEHC-1778544497129 |
Track record
13 reports on GEHC
2 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +19.07% at T+20 after the Oct 19, 2026 report. 2 of 3 went positive at some point.
Filters
- Nov 5, 202611d ago 8-K Neutral 3/10 Entry $83.75 to $81.84 Now $82.96 −0.94% ▼ −2.28% −5.57% vs SPY
- Nov 4, 202612d ago 144 Neutral 2/10 Entry $83.75 to $81.84 Now $82.96 −0.94% ▼ −2.28% −5.57% vs SPY
- Oct 28, 202619d ago 8-K Bullish 6/10 Entry $75.82 to $85.81 Now $82.96 +9.42% ▲ +13.18% +13.89% vs SPY
- Oct 19, 202628d ago Institutional Cluster Bullish 4/10 Entry $69.72 to $71.60 Now $82.96 +18.99% ▲ +2.70% +2.84% vs SPY
- Sep 22, 20267w ago 8-K Neutral 2/10 Entry $66.09 to $65.37 Now $82.96 +25.53% ▼ −1.09% −0.41% vs SPY
- Sep 16, 20268w ago 3 Neutral 2/10 Entry $64.45 to $66.38 Now $82.96 +28.73% ▲ +3.00% +2.40% vs SPY
- Jul 29, 202615w ago 8-K Neutral 2/10 Entry $71.90 to $70.24 Now $82.96 +15.38% ▼ −2.31% −7.84% vs SPY
- May 13, 202626w ago Insider Cluster Neutral 2/10 Entry $64.26 to $62.86 Now $82.96 +29.10% ▼ −2.18% −3.98% vs SPY
- May 11, 202627w ago 8-K Neutral 2/10 Entry $62.29 to $61.51 Now $82.96 +33.18% ▼ −1.25% −1.33% vs SPY
- Apr 30, 202628w ago Insider Cluster Neutral 4/10 Viewing Entry $60.96 to $63.40 Now $82.96 +36.09% ▲ +4.00% +1.64% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers